Clinical Trial Update: NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD [Phase 2]

View source ↗

Summary

Phase 2 trial comparing NRP104, Adderall XR, and placebo in children aged 6-12 with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Adderall XR (mixed amphetamine salts)
• NRP104

Snippet

Sponsor: New River Pharmaceuticals | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED